Michael Frohman was an undergraduate at the University of Michigan (B.S. with Distinction and High Honors in Chemistry and High Honors in Cellular & Molecular Biology), undertook MD-PhD (immunology) training at the University of Pennsylvania, and was a postdoctoral fellow at UCSF prior to becoming a faculty member in the Department of Pharmacological Sciences at Stony Brook University in 1992. Institutional activities have included initiating a university core in Molecular Cloning, being Director of the Medical Pharmacology course for eight years, Director of the NIH-funded MSTP (MD-PhD) training program since 2003, and Chair of Pharmacological Sciences since 2007. Michael’s major research accomplishments have involved development of the cloning protocol know as 5′ RACE-PCR and cloning and characterization of the Phospholipase D superfamily of lipid signaling enzymes, for which small molecule therapeutics are now in development to target thrombotic disease and cancer. Michael, who has been continuously funded from the NIH since 1993, has authored nearly 200 reports (h-index 70) and has been recognized with a School of Medicine Excellence in Faculty Mentoring Award, by election into the Association of American Physicians (AAP), and as a Fellow in AAAS.